Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and Performance of Etermis 3 and 4 in Wrinkles/Folds Treatment and Facial Volume Enhancement: A Prospective, Evaluator-Blinded, Open-Label Study.
Sattler G, Kerscher M, Noah EM, Prager W, Fischer TC, Ogilvie P, Hofmann M, Dersch H, Odena G. Sattler G, et al. Among authors: ogilvie p. Clin Cosmet Investig Dermatol. 2020 Aug 19;13:591-599. doi: 10.2147/CCID.S244598. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 32884321 Free PMC article.
Phase 3 Study of OnabotulinumtoxinA Distributed Between Frontalis, Glabellar Complex, and Lateral Canthal Areas for Treatment of Upper Facial Lines.
De Boulle K, Werschler WP, Gold MH, Bruce S, Sattler G, Ogilvie P, Street J, Larsen KE, Yushmanova I, Lei X, Lee E, Vitarella D, Mao C. De Boulle K, et al. Among authors: ogilvie p. Dermatol Surg. 2018 Nov;44(11):1437-1448. doi: 10.1097/DSS.0000000000001612. Dermatol Surg. 2018. PMID: 30096106 Clinical Trial.
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Single-Dose, Phase III, Non-Inferiority Study Comparing PrabotulinumtoxinA and OnabotulinumtoxinA for the Treatment of Moderate to Severe Glabellar Lines in Adult Patients.
Rzany BJ, Ascher B, Avelar RL, Bergdahl J, Bertucci V, Bodokh I, Carruthers JA, Cartier H, Delmar H, Denfeld R, Gross JE, Heckmann M, Hedén P, Hilton S, Inglefield C, Ogilvie P, Sattler G, Sebastian M, Solish N, Swift A, Trévidic P. Rzany BJ, et al. Among authors: ogilvie p. Aesthet Surg J. 2020 Mar 23;40(4):413-429. doi: 10.1093/asj/sjz110. Aesthet Surg J. 2020. PMID: 30951166 Clinical Trial.
Expert Consensus on Injection Technique and Area-Specific Recommendations for the Hyaluronic Acid Dermal Filler VYC-12L to Treat Fine Cutaneous Lines.
Ogilvie P, Thulesen J, Leys C, Sykianakis D, Chantrey J, Safa M, Figueiredo V, Heydenrych I, Cavallini M, Langeland EK, Wetter A. Ogilvie P, et al. Clin Cosmet Investig Dermatol. 2020 Apr 5;13:267-274. doi: 10.2147/CCID.S239667. eCollection 2020. Clin Cosmet Investig Dermatol. 2020. PMID: 32308460 Free PMC article.
PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data.
Solish N, Ascher B, Avelar RL, Bertucci V, Bodokh I, Carruthers J, Cartier H, Delmar H, Denfeld R, Heckmann M, Hedén P, Hilton S, Inglefield C, Ogilvie P, Rzany BJ, Sattler G, Sebastian M, Swift A, Trévidic P. Solish N, et al. Among authors: ogilvie p. Aesthet Surg J. 2022 Dec 14;42(12):1460-1469. doi: 10.1093/asj/sjac210. Aesthet Surg J. 2022. PMID: 35922149 Free PMC article. Clinical Trial.
45 results